New molecular markers for detection of squamous cell carcinomas and adenocarcinomas and high-grade precursor lesions thereof
A technology for squamous cell carcinoma, grade carcinoma, applied in the field of diagnostics, can solve the problem of lack of sensitivity in malignant diseases
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0081] 1. Differentially expressed genes in tissues and cell lines
[0082] To confirm the differential expression of the genes listed in Tables 1 and 2, we measured the mRNA expression of the following genes by real-time RT-PCR analysis: ITGAV, SYCP2, DTX3L, SEMP1, DEK, ATP2C1, SLC25A36, and PIK3R4. For this purpose, samples from 22 cervical squamous cell carcinomas, 8 cervical adenocarcinomas, 15 high-grade cervical epithelial neoplasia (CIN) lesions, and 24 normal epithelial controls (n = 13 for normal RNA was extracted from neck n=11). ITGAV, SYCP2, DTX3L, SEMP1, DEK, ATP2C1, PIK3R4, and SLC25A36 showed significant overexpression in squamous cell carcinomas compared with normal ectocervix (see e.g. figure 1 ). Additionally, DTX3L showed significant overexpression in adenocarcinoma compared with normal endocervix ( figure 1 ). Analysis of RNA isolated from 15 high-grade CIN lesions enriched in dysplastic cells by laser capture microdissection confirmed increased express...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com